Coherus Oncology, Inc. (CHRS) Earnings
NASDAQ·Healthcare·Biotechnology
$1.42
+2.17%
Mkt Cap $177.49M
EPS — Estimate vs Actual
Mkt Cap
$177.49M
P/E
1.27
Fwd P/E
—
P/S
3.79
Rev TTM
—
EPS TTM
-$1.28
NASDAQ·Healthcare·Biotechnology
$1.42
+2.17%
Mkt Cap $177.49M
Mkt Cap
$177.49M
P/E
1.27
Fwd P/E
—
P/S
3.79
Rev TTM
—
EPS TTM
-$1.28